TW200515912A - Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep - Google Patents

Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep

Info

Publication number
TW200515912A
TW200515912A TW093126564A TW93126564A TW200515912A TW 200515912 A TW200515912 A TW 200515912A TW 093126564 A TW093126564 A TW 093126564A TW 93126564 A TW93126564 A TW 93126564A TW 200515912 A TW200515912 A TW 200515912A
Authority
TW
Taiwan
Prior art keywords
pain
sleep
improvement
treatment
oxcarbazepine
Prior art date
Application number
TW093126564A
Other languages
Chinese (zh)
Inventor
Donald Manning
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200515912A publication Critical patent/TW200515912A/en

Links

Abstract

The present invention provides for novel uses of the carbamazepine derivative of formula I, and its pharmaceutically acceptable salts, in particular an improved regimen for the administration of the carbamazepine derivative of formula I and the pharmaceutically acceptable salts thereof for the treatment of patients suffering from pain, in particular neuropathic pain, especially diabetic neuropathic pain, and the improvement of sleep; the use of oxcarbazepine for the manufacture of a pharmaceutical composition for the treatment of pain or the manufacture of a pharmaceutical composition for the improvement of sleep in human patients suffering from chronic pain; pharmaceutical compositions comprising oxcarbazepine as sole active ingredient for the treatment of pain or for the improvement of sleep in human patients suffering from chronic pain and to packages comprising a pharmaceutical composition comprising as sole active ingredient oxcarbazepine together with instructions for the treatment of pain or together with instructions for improvement of sleep in human patients suffering from chronic pain.
TW093126564A 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep TW200515912A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0320637A GB0320637D0 (en) 2003-09-03 2003-09-03 Organic compounds
US53737804P 2004-01-16 2004-01-16

Publications (1)

Publication Number Publication Date
TW200515912A true TW200515912A (en) 2005-05-16

Family

ID=28686842

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093126564A TW200515912A (en) 2003-09-03 2004-09-02 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep

Country Status (4)

Country Link
CN (1) CN1845743A (en)
GB (1) GB0320637D0 (en)
TW (1) TW200515912A (en)
ZA (1) ZA200601502B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4003357A1 (en) * 2019-07-23 2022-06-01 Astellas Pharma Global Development, Inc. Methods of treating sleep disorders associated with pain

Also Published As

Publication number Publication date
ZA200601502B (en) 2007-04-25
CN1845743A (en) 2006-10-11
GB0320637D0 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2006133941A3 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
WO2008027557A3 (en) Topiramate compositions and methods of enhancing its bioavailability
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MXPA05007857A (en) Indole-derivative modulators of steroid hormone nuclear receptors.
MX2009002314A (en) Pharmaceutical compositions comprising hgh for oral delivery.
EP2392322A3 (en) Dosing regimes for trans-clomiphene
UA92498C2 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
MX2009011900A (en) Diabetic wound healing.
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TNSN06072A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
EA201100916A1 (en) COMBINATION OF INSULIN WITH TRIAZINE DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DIABETES
IL179177A (en) Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition
RU2007119067A (en) MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200515912A (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
TW200626133A (en) Oral medication for twice-daily administration
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
BRPI0503488A (en) treatment agent for irritable bowel syndrome with predominant diarrhea
DE50311479D1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING OXCARBAZEPINE WITH CONTROLLED ACTIVE INGREDIENTS
EA200501366A1 (en) MEDICINE